This week the UK's weight-loss market moved from injections-only to pill-in-hand. A daily Wegovy tablet is now being listed by major UK pharmacies and online clinics, while NHS access to Mounjaro has widened on paper for some patients.
There was also a notable NHS development outside weight loss: London's Evelina Hospital has opened a dedicated hair loss clinic for children. The wider pattern is familiar for UK patients comparing options: private access moves quickly, while NHS pathways expand more gradually.
In this round-up
The Wegovy tablet is now appearing across UK pharmacies
On 7 July 2026, the daily Wegovy tablet, oral semaglutide, went on sale through a range of UK pharmacies and online clinic brands. The medicine was approved by the MHRA on 11 June as the UK's first oral GLP-1 medicine for weight management.
It is licensed for adults with a BMI of 30 or above, or 27 to 30 with a weight-related health condition, alongside diet and exercise changes. Trial reporting for the highest 25mg dose described average weight loss of around 17% after 64 weeks.
| Provider | Advertised entry price | What to check |
|---|---|---|
| Numan | From £66 | Introductory plan pricing and longer commitment terms. |
| Asda Online Doctor | £98.97 | Starter dose price and higher-dose ladder. |
| Superdrug | £99 | Initial dose availability and later-dose pricing. |
| Lloyds Pharmacy | £109.99 | Starter dose pricing and ongoing monthly cost. |
| Morrisons Clinic | £119 | Starter dose price and dose escalation costs. |
| Boots | £119 to £229 | Full dose range, consultation terms and support included. |
If needles were the main reason you avoided GLP-1 treatment, this is now a real comparison point. But the useful number is not just the lowest advertised first-month price. Check the full dose ladder, whether the price is promotional, and what clinical support is included before choosing a provider.
NHS Mounjaro access has widened, but it is still a phased rollout
From July 2026, NHS specialist weight-management services widened tirzepatide, Mounjaro, eligibility to include some people with a BMI of 35 to 39.9 who also have at least four qualifying weight-related health conditions.
The criteria use lower BMI thresholds for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds, reflecting evidence that weight-related health risks can appear at a lower BMI in these groups.
If you were previously outside the BMI threshold, it may be worth asking your GP whether the new specialist-service criteria apply. This is not blanket GP prescribing, so expect referral pathways and local capacity to matter.
The UK's first NHS hair loss clinic for children has opened in London
St John's Institute of Dermatology and Evelina London Children's Hospital, part of Guy's and St Thomas' NHS Foundation Trust, have launched a dedicated NHS clinic for children and young people with hair loss.
The service covers conditions including alopecia areata, trichotillomania, thyroid-related hair loss, vitamin deficiency-related hair loss and hair loss after chemotherapy. It is expected to see around 70 children and young people a year.
If your child is dealing with hair loss, ask your GP what NHS referral options exist before assuming a private route is the only option.
Beyond weight loss: hair treatments and at-home diagnostics
- VDPHL01 has completed enrolment across its male Phase 3 studies for pattern hair loss, moving the programme closer to large-scale efficacy and safety read-outs.
- Cinainu, a topical botanical treatment made from four plant extracts, showed hair regrowth in children and adolescents with moderate to severe alopecia areata, according to trial results published in the British Journal of Dermatology.
- Thriva has moved from traditional finger-prick lancets to a shoulder-based blood draw device, aimed at reducing failed or insufficient samples.
- Lola Health, an at-home phlebotomy blood-testing service, lists panels from £130 for its Essential panel to £250 for its Complete Longevity panel.
- Medichecks remains one of the broadest UK blood-test menus, with hundreds of individual tests and panels available.
Women's health: the NHS is planning a more digital front door
- NHS England is planning a digital-first online hospital, accessed through the NHS App, with menopause and menstrual conditions expected to be early priorities from 2027.
- The Women's Digital Health Challenge has expanded from 2 to 26 supported innovations, including tools for menopause and breast health awareness.
- NHS leaders continue to push women's health hubs that combine services into fewer appointments and reduce fragmented care.
Market and investment signals
- NHS England has committed funding to ambient voice technology, AI tools that help turn patient-clinician conversations into medical notes, as part of wider digital investment.
- Government health innovation funding continues to focus on faster access to drugs, devices and medical technologies.
- UK digital health funding remains weighted toward clinical workflow software, rather than direct-to-consumer comparison or prescribing products.
Medical disclaimer
This article is for general information only and is not medical advice. GLP-1 medicines are prescription-only treatments. Always speak to a qualified healthcare professional before making decisions about weight-loss medication, changing treatment, or choosing a provider.
Sources
- First GLP-1 tablet for weight loss approved in the UK, GOV.UK
- First GLP-1 pill for weight loss approved in the UK, Diabetes.co.uk
- New price changes for Mounjaro, Numan
- Weight-loss pills to be sold by Morrisons, Boots and Superdrug, Yahoo News
- Weight Loss Injections on the NHS: Who Qualifies in 2026, Earlsdon Pharmacy
- UK's first hair loss clinic for children, Guy's and St Thomas' NHS Foundation Trust
- Best Blood Test Kits UK 2026: Complete Guide, Lola Health
- Women's health programme expands from 2 to 26 innovations, NHS England
- DHSC and NHSE internal plan pledges £7.4bn digital investment, Digital Health News
- Government ploughs £197m into new health and medical technologies, Building Better Healthcare
- Digital Health Startup Funding 2025-2026, New Market Pitch
